China Universal Asset Management Co. Ltd. Has $4.58 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

China Universal Asset Management Co. Ltd. boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 34.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,318 shares of the medical equipment provider’s stock after acquiring an additional 2,374 shares during the period. China Universal Asset Management Co. Ltd.’s holdings in Intuitive Surgical were worth $4,578,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Ridgewood Investments LLC acquired a new stake in shares of Intuitive Surgical in the second quarter worth $26,000. Godsey & Gibb Inc. grew its position in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the last quarter. Creekmur Asset Management LLC increased its holdings in shares of Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares during the period. LGT Financial Advisors LLC raised its holdings in Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 54 shares in the last quarter. Finally, Delos Wealth Advisors LLC increased its holdings in Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 2,128 shares of the business’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,095,920.00. Following the sale, the senior vice president now owns 273 shares of the company’s stock, valued at $140,595. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, Director Amal M. Johnson sold 2,943 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the completion of the sale, the director now owns 12,275 shares of the company’s stock, valued at $5,441,507.50. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Mark Brosius sold 2,128 shares of Intuitive Surgical stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the sale, the senior vice president now owns 273 shares of the company’s stock, valued at $140,595. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 51,838 shares of company stock worth $25,241,950 in the last ninety days. Company insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the company. Morgan Stanley increased their price objective on Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a research note on Monday, July 15th. Truist Financial boosted their target price on Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday, October 18th. JPMorgan Chase & Co. boosted their target price on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Finally, The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Trading Down 0.1 %

Intuitive Surgical stock opened at $510.88 on Tuesday. The company has a market capitalization of $181.97 billion, a PE ratio of 82.14, a P/E/G ratio of 5.11 and a beta of 1.39. The stock has a 50-day moving average price of $488.56 and a two-hundred day moving average price of $443.89. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $523.34.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.